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Background: Brinps 1–3, and Astrotactins (Astn) 1 and 2, are members of the
Membrane Attack Complex/Perforin (MACPF) superfamily that are predominantly
expressed in the mammalian brain during development. Genetic variation at the human
BRINP2/ASTN1 and BRINP1/ASTN2 loci has been implicated in neurodevelopmental
disorders. We, and others, have previously shown that Brinp1−/− mice exhibit behavior
reminiscent of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder
(ADHD).
Method: We created Brinp2−/− mice and Brinp3−/− mice via the Cre-mediated
LoxP system to investigate the effect of gene deletion on anatomy and behavior.
Additionally, Brinp2−/−Brinp3−/− double knock-out mice were generated by
interbreeding Brinp2−/− and Brinp3−/− mice. Genomic validation was carried out
for each knock-out line, followed by histological, weight and behavioral examination.
Brinp1−/−Brinp2−/−Brinp3−/− triple knock-out mice were also generated by crossing
Brinp2/3 double knock-out mice with previously generated Brinp1−/− mice, and
examined by weight and histological analysis.
Results: Brinp2−/− and Brinp3−/− mice differ in their behavior: Brinp2−/− mice are
hyperactive, whereas Brinp3−/− mice exhibit marked changes in anxiety-response on
the elevated plus maze. Brinp3−/− mice also show evidence of altered sociability. Both
Brinp2−/− and Brinp3−/− mice have normal short-term memory, olfactory responses,
pre-pulse inhibition, and motor learning. The double knock-out mice show behaviors of
Brinp2−/− and Brinp3−/− mice, without evidence of new or exacerbated phenotypes.
Conclusion: Brinp3 is important in moderation of anxiety, with potential relevance to
anxiety disorders. Brinp2 dysfunction resulting in hyperactivity may be relevant to the
association of ADHD with chromosome locus 1q25.2. Brinp2−/− and Brinp3−/− genes
do not compensate in the mammalian brain and likely have distinct molecular or cell-type
specific functions.
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INTRODUCTION
BMP/RA-inducible neural-specific protein(s) (Brinps) are a
family of three highly conserved vertebrate genes that are almost
exclusively expressed in neurons in the central and peripheral
nervous system (Kawano et al., 2004; Terashima et al., 2010).
They form part of a larger protein superfamily exemplified
by the membrane attack complex/perforin (MACPF) domain.
Brinp2 and Brinp3 are expressed in differentiated neurons of
the neocortex, amygdala, hippocampus, and cerebellum during
mammalian brain development, peaking at postnatal day 14
(Kawano et al., 2004). In the adult mouse brain, Brinp2 and
Brinp3 gene expression is reduced and region-specific expression,
unlike the more ubiquitous expression of Brinp1. Brinp2 and
Brinp3 show a partial temporal and regional overlap in expression
during development of the mammalian brain (Kawano et al.,
2004). High homology between Brinp2 and Brinp3 amino acid
sequence (70% identity) suggests that these two genes evolved
by duplication of a common ancestor (Kawano et al., 2004;
Giousoh et al., 2015), and may perform a similar, interchangeable
function—to the extent that one may compensate for the
other’s absence. Furthermore, Brinp1 is ∼50% homologous to
Brinp2 and Brinp3, suggesting all three Brinps have related roles
(Kawano et al., 2004).
BRINP2, BRINP3, and the MACPF superfamily member
Astrotactin1 (ASTN1) are co-located in humans at chromosome
1q25.2, and in mice (Giousoh et al., 2015). Genetic variations
at the 1q25.2 locus are associated with neurodevelopmental
disorders, in particular attention deficit hyperactivity disorder
(ADHD) (Lesch et al., 2008; Romanos et al., 2008). Two copy
number variations (CNV)—one deletion and one duplication—
are reported in patients with neurodevelopmental disorders
(NDDs) that span the ASTN1/BRINP2 loci, suggesting that one
or both of these genes is responsible for the neuropathology
(Lionel et al., 2014). The patient with a CNV gain had anxiety,
ASD, learning disability, and motor delay, whereas the patient
with the deletion suffered developmental delay and seizures
(Lionel et al., 2014). In addition, BRINP2 has been linked to
substance abuse and reward dependence in two genome-wide
association studies (Verweij et al., 2010; Drgon et al., 2011).
Patients diagnosed with schizophrenia show altered methylation
states of Brinp3 (Numata et al., 2014). Changes in BRINP3
(FAM5C) levels have also been reported to correlate with changes
in the neurotransmitter norepinephrine during exercise (Karoly
et al., 2012).
In non-NDD diagnoses, overexpression of BRINP2
(FAM5b) or BRINP3 (FAM5c) has been implicated in cancer:
BRINP2 is amplified in oral squamous cell carcinoma (Cha
et al., 2011), and BRINP3 is overexpressed in pituitary
adenomas (Shorts-Cary et al., 2007). Both genes also show
association with coronary heart disease (Connelly et al.,
2008; Angelakopoulou et al., 2012). Presentation in similar
disease suggests a common molecular function of BRINP2 and
BRINP3.
Brinp1 was the first of the three Brinp genes to be studied
in mice. Brinp1−/− mice generated by our group and others
show hyperactivity, decreased body weight, reduced reproductive
success, impaired short-term memory, altered anxiety response,
and social communication impairments reminiscent of autism
spectrum disorder (ASD). In the adult brain, Brinp1−/−
mice exhibit increased parvalbumin-interneuron density in the
neocortex and hippocampus (Kobayashi et al., 2014; Berkowicz
et al., 2016).
In this study, the key aims were to determine the effect of
loss of Brinp2 and/or Brinp3 on mouse anatomy and behavior,
and to gain insight into the (potentially overlapping) function
of these genes and their relationship with neurodevelopmental
disorders. To investigate if compensation by Brinp2 or Brinp3
masks a more severe phenotype in the Brinp1−/− mice,
Brinp1−/−Brinp2−/−Brinp3−/− (Brinp1/2/3) triple knock-out
mice were also generated and studied.
MATERIALS AND METHODS
Gene Targeting
Gene targeting methods were similar to those described
for the generation of Brinp1−/− mice (Berkowicz et al.,
2016). A targeting vector was constructed to alter the Brinp2
locus in mouse embryonic stem (ES) cells by homologous
recombination following the general strategy outlined in Teoh
et al. (2014). Separately, a targeting vector was constructed
to alter the Brinp3 locus in ES cells. The vectors were built
using bacterial artificial chromosome (BAC) clones RP23-
97A3 and RP23-213F2 as the source of Brinp2 DNA, and
BACs RP23-146N23/RP23-301J4 as the source of Brinp3 DNA.
Both the Brinp2 and Brinp3 vectors comprised a neomycin
transcriptional unit flanked by flippase (Flp) recognition
target (FRT) elements placed in intron 3. For each vector,
a loxP element was placed in the same intron immediately
downstream of the neomycin cassette, while an upstream loxP
element was placed in intron 2. Cre-recombinase mediated
deletion of exon 3 was designed to result in a frame shift,
creating a stop codon in the fourth exon. The Brinp2 and
Brinp3 targeting constructs were separately electroporated into
Bruce 4 C57BL/6-derived embryonic stem (ES) cells, and
the targeted clone carrying the targeted allele Brinp2tm1Pib
(MGI:5604614) or Brinp3tm1Pib (MGI:5604619) were identified
by Southern analysis. A correctly targeted clone for each gene
was injected into BALB/c blastocysts to generate chimeric
mice. Chimeric Brinp2tm1Pib and chimeric Brinp3tm1Pib mice
were each crossed to C57BL/6 Cre-deleter transgenic mice
(Tg(CMV-cre)1Cgn) to remove exon 3 and the neomycin
cassette from the targeted allele to produce animals carrying
the Brinp2tm1.1Pib mutation (MGI:5604615) or Brinp3tm1.1Pib
mutation (MGI:5604620). In parallel, chimeric mice were
crossed to C57BL/6 Flp-deleter transgenic mice to remove
the neomycin cassette only [Brinp2tm1.2Pib (MGI:5604617);
Brinp3tm1.2Pib (MGI:5604621)]. “Floxed” mice heterozygous for
the Brinp2tm1.1Pib mutation were inter-crossed to generate
mice of all three genotypes: Brinp2+/+ (WT); Brinp2+/tm1.1Pib
(het); and Brinp2tm1.1Pib/tm1.1Pib (Brinp2−/−). “Floxed” mice
heterozygous for the Brinp3tm1.1Pib mutation were inter-crossed
to generate mice of all three genotypes: Brinp3+/+ (WT);
Brinp3+/tm1.1Pib (het); and Brinp3tm1.1Pib/tm1.1Pib (Brinp3−/−).
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Genomic Analysis
Mice carrying the Brinp2−/− and Brinp3−/− floxed alleles, along
with their respective WT, targeted, and Flpe mouse lines were
all verified by Southern analysis. Genomic DNA isolated from
the spleen was digested with AseI (Brinp2) or NdeI (Brinp3)
and probed with a 500 bp 5′ homology probe. A 3′ homology
arm probe was used for blotting of genomic DNA digested with
BglII (Brinp2) PvuII (Brinp3). An internal probe was used to
rule out random integration into the genome. Genotyping PCR
confirmed absence of the neomycin cassette in floxed animals.
Breeding Brinp2/3−/− Double Knock-Out
Mice
Brinp2−/− mice were mated with Brinp3−/− mice. The resultant
heterozygous offspring were bred, avoiding sibling matings. As
both genes are present on chromosome 1q (separated by 11.8M
bp) offspring were screened for a crossover event occurring
between the Brinp2tm1.1Pib allele and the Brinp3tm1.1Pib allele,
resulting in a chromosomewith themutant version of both genes.
The presence of a Brinp2tm1.1Pib Brinp3tm1.1Pib chromosome
was screened for as a genotyping result showing a mouse
homozygous for one floxed gene, and heterozygous for the
other—a scenario only possible if a cross-over event has occurred.
Mice found to have Brinp2tm1.1Pib and Brinp3tm1.1Pib on the
same chromosome were bred to generate Brinp2/3−/− mice.
Brinp2/3−/− mice were identified by genotyping PCR, and
validated by reverse-transcriptase PCR (RT-PCR).
Brinp2/3 knock-out mice were maintained as a homozygous
colony to prevent recombination re-occurring in order to
conserve the Brinp2/Brinp3tm1PB alleles. A WT line from the
same parental origins was maintained in parallel.
Breeding Brinp1/2/3−/− Triple Knock-Out
Mice
Female Brinp2/3−/− mice were bred with male Brinp1−/− mice,
resulting in mice heterozygous for Brinp1tm1.1Pib, Brinp2tm1.1Pib,
and Brinp3tm1.1Pib. Triple heterozygous mice were mated to
generate Brinp1/2/3−/− mice at an expected frequency of
1/16, along with WT littermates. Additionally, male mice of
genotype Brinp1+/−/2−/−/3−/− were mated with female triple
heterozygous mice in an attempt to increase triple knock-
out mice frequency. Brinp1/2/3−/− mice were identified by
genotyping PCR, and validated by RT-PCR.
RT-PCR
RNA was extracted from the whole brain of WT, het and
knock-out mice from each Brinp line and reverse transcribed
into cDNA (SSIII First Strand Synthesis, Life Sciences).
Primers used for Brinp1 primers were designed to Exon
2: 5′-CTGGGACAGACCAACATGTCTC and Exon 6: 3′-
GCTCTCCGTGCTTTGCAGAAGG, to produce a 526 bp WT
product or a 336 bp floxed product.
Brinp2 primers were designed to Exon 2: 5′-GGACTGGCT
GCTCACAGACCG and Exon 4: 3′-GTGCTCTCTCTGTCAAT
GAAG, to produce a 439 bp WT product or a 247 bp floxed
product.
Brinp3 primers were designed to Exon 2: 5′-CCCCTTCGAC
TGGCTCCTCTC and Exon 5: 3′-CCTGTCCGTGTTTCTGTCA
CC, to produce a 510 bp WT product or a 221 bp floxed product.
PCR conditions: 95◦C 60 s (95◦C 30 s, 61◦C 30 s, 72◦C 30 s)× 35,
72◦C 120 s. RT-PCR products were cut out of a 2% agarose gel
and sequenced.
Animals
C57BL/6 floxed mice and wild type littermates were generated
from heterozygous breeders in all studies. Mice were genotyped
from tail snips collected at postnatal day 10 (P10). For
each knock-out line, mice were housed with mixed genotype
littermates; with a maximum of five adults per box. Mice were
housed in individually ventilated, sawdust lined Thoren cages,
and fed ad libitum on Barastoc rodent feed with constant access
to water. Mice were maintained on a 12 h light/dark cycle (light
7 a.m.–7 p.m.) and with a controlled room temperature of 18–
24◦C. Cages and bedding were changed weekly. All breeding and
experiments were approved by the Monash University Animal
Ethics Committee.
Weighing
Brinp2−/−, Brinp3−/− Brinp2/3−/−, Brinp1/2/3−/− mice, along
with their respective WT littermates were weighed weekly
between 3 and 12 weeks.
Histology
Twenty-five organs per mouse were compared to their respective
WT littermates from juvenile (7–8 week old) Brinp2−/−,
Brinp3−/−, Brinp2/3−/−, and Brinp1/2/3−/− mice. Tissue was
prepared as formalin fixed, paraffin wax embedded sections
(10µm). Hematoxylin and Eosin (H&E) staining was carried
out by the Australian Phenomics Network (http://www.
australianphenomics.org.au/). Histopathological assessments
and clinical hematological analysis was performed on two
mice per genotype and compared to WT littermates. The
same 25 organ types were examined for macromorphological
abnormalities as previously described (Berkowicz et al., 2016).
For a list of organs examined, refer to the characterization of
Brinp1−/− mice.
Reproductive Phenotyping
Three breeding pairs per genotype (WT/WT, Triple-Het/Triple-
Het, and Triple-Het ♂/Brinp1−/+2−/−3−/− ♂) were set up and
monitored over 5 months. Mice were first used as breeders at 7–8
weeks of age. The number of pups were recorded at birth and at
weaning (postnatal day 21).
Behavioral Testing
Cohort sizes were 9–12 mice, aged 3–4 months. Where possible,
a ratio of 1:1 females/males was tested. Mice were habituated to
the testing facility for 1 week, then habituated to the testing room
overnight. Mice were tested by experimenters blind to genotype
and in random order. Tests were separated by a minimum of
1 day. WT and knock-out mice were tested in the same testing
sessions. Lighting conditions were 30 lux for all behavioral tests.
Testing arenas were cleaned with Equinade disinfectant (lavender
scent) between trials. In all instances, mice had previously
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been habituated to the disinfectant whilst housed at the testing
facility. Behavioral tests were performed in an identical manner
to previously described for the behavioral characterization of
Brinp1−/− mice (Berkowicz et al., 2016), as follows.
Visual Placing Test
Mice were lifted by the tail to a height of 15 cm and lowered
onto a mesh grid within 1 s, decelerating as the grid approached.
The distance of the animal’s nose from the grid was measured
the moment before the mouse extended its forelimbs toward it. A
single trial was performed per animal.
Olfaction Test
Relative levels of sniffing behavior was investigated within an area
that contained 2 squares of filter paper (4× 4 cm), one containing
275 µl of peanut butter (at three dilutions—1:10; 1:100; 1:1000)
and one containing 275 µl of water, over a 3min period. The
animals were first acclimatized to the area for a 15 min period.
Rotarod
Mice were pre-trained on the Rotarod (Ugo Basil) for two initial
trials at a constant speed of 4 rpm for 5 min, followed by a third
trial accelerating from 4 to 40 rpm over 5min. Testing was carried
out the following day by 4 × 5min accelerating trials with an
inter-trial interval of 30min.
Elevated Plus Maze
Mice were placed on an elevated platform (material: Perspex,
color: beige) at a height of 40 cm above the floor. The platform
comprised of two open arms and two closed arms (each 4.5 cm
wide, 30 cm in length), connected by a central square (6 ×
6 cm). The two closed arms were protected by a 15 cm high
wall. Mice were placed on the center square and video recorded
whilst exploring the maze. Time and frequency of entry into
each arm, and average velocity throughout the trial time of 5
min were recorded. Tracking software: Noldus Ethovision 3.0.
Frequency of peering down, and entries to the far end of the
open arm, were counted manually. Entries into the far ends of
the open arms were defined as all feet greater than halfway along
the arm.
Y-Maze
Mice were tested in two trials of a Plexiglass Y-maze (material:
Perspex, color: gray) with each of the three arms having a
distinctive visual cue at the end. Dimensions of each arm were
30 × 10 cm, with a triangle center zone of 10 cm equal sides.
Mice received a random association between visual cues and arm
location. In Trial 1, a partition blocked off the left arm of the
maze. The mouse was placed at the end of the home arm, facing
away from the center. The time spent in each of the two available
arms over 10 min was recorded. Mice were rested for 2 h. In
trial 2, testing was repeated in a second trial with the partition
removed and all three arms made accessible. Time in each arm
and average velocity was recorded for trial 2 for 10 min. Tracking
software: Noldus Ethovision XT 5.0.
Acoustic Startle and Pre-pulse Inhibition
(PPI)
Mice were placed individually inside a Perspex cylinder, closed
at both ends. The cylinder was placed upon a platform sensitive
to weight displacement, within a sound attenuating box with a
background sound level (San Diego Instruments Startle Response
System). The background white noise level was set to 70 dB. To
measure acoustic startle, a strong 40ms startle sound was played
and startle response wasmeasured by the jumping reflex (<1 s) as
weight displacement on the platform. Pre-Pulse Inhibition (PPI)
was measured as the percentage reduction in startle response
when a non-startling 20ms pre-pulse of (a) 4 db (b) 8 db (c) 16 db
above the 70 dB background sound was played 100ms prior to
the startle sound.
Three Chamber Social Interaction Test
Identical rectangular wire cages were placed in equivalent
positions in the left and right chambers of a three-chamber
plexiglass box (600 × 400 × 250mm). Mice were habituated to
the empty cages in the left and right chambers (trial 1) and time
interacting with each cage was recorded. In trial 2, an unfamiliar
C57BL/6J WT sex-matched mouse was introduced to one of the
cages, and time interacting with each cage was again recorded.
Each trial lasted 10 min, with average velocity recorded for each
trial. The mice serving as strangers were habituated to placement
under the wire cage for 5 min prior to the test. Mice were tracked
using Cleversys Tracking and Topscan software. The interaction
zone was defined by the software as an unmarked perimeter zone
of 2 cm around the metal cages. Interaction time was defined
as nose within the interaction zone. The chambers were cleaned
between trials with Equinade disinfectant (lavender scent).
Statistical Analysis
Survival rates of total numbers of mice weaned was analyzed by
Chi-square test. Number of survivingmice per litter was analyzed
by one-way ANOVA. Postnatal weight, olfaction test, Rotarod,
Elevated Plus Maze, and Y-maze performance, and PPI analyzed
by repeat measures two-way ANOVA. Vision test, startle
response and EPM and Y-maze secondary data was analyzed
by Student t-test. Habituation trials and social interaction test
were analyzed by one-way ANOVA. Average velocity for trial 1
(habituation) and trial 2 of the social interaction test was analyzed
by two-way repeat measures ANOVA. Male and female mice
were analyzed separately, unless otherwise stated. Behavioral data
was represented as the mean ± standard deviation. A value of
p < 0.05 was used to determine significance.
RESULTS
Targeting of Brinp2 Knock-Out Mice
A conditional Brinp2 targeted allele (Brinp2tm1/Pib) was designed
to allow Cre-recombinase-mediated, tissue-specific deletion
of Brinp2 (Figure 1A). Mice lacking Brinp2 in all tissues
were generated by breeding animals carrying the targeted
allele with animals expressing Cre-recombinase from the two-
cell embryonic stage onwards (global Cre-deleter). Progeny
exhibiting deletion of the selection cassette and third exon of
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FIGURE 1 | Brinp2 and Brinp3 Targeting. (A) The Brinp2 targeting vector was designed with a Neomycin resistance (Neo-r) cassette after exon 3, and FRT sites
placed before and after the Neo-r cassette. The 192bp 3rd exon of Brinp2 contains the start of the Membrane Attack Complex/Perforin (MACPF) domain. LoxP sites
flank exon 3 and the Neo-r cassette. When crossed with a global Cre-deleter mouse line, the recombination of LoxP sites resulted in the deletion of exon 3 and the
Neo-r cassette. (B) Brinp2 Southern Blot: splenic genomic DNA was cleaved with PstI and BglII and hybridized to 500 bp genomic DNA probes from the 5′ region
(Continued)
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FIGURE 1 | Continued
(Asel) and 3′ region (Bgl II) of the targeting construct. In wild-type DNA, species of 23.1 kb (Asel) and 8.1 kb (Bgl II) were detected. The 8.1 kb (Bgl II) species was not
present in DNA from Brinp2−/− mutants, replaced with shorter species 7.4 kb (BglII). (C) The Brinp3 targeting vector was designed with a Neo-r cassette after exon
3, and FRT sites positioned before and after the Neo-r Cassette. The 289bp 3rd exon of Brinp3 contains the start of the MACPF domain. LoxP sites flank exon 3 and
the Neo-r cassette. When crossed with a global Cre-deleter mouse line, the recombination of LoxP sites resulted in the deletion of exon 3 and the Neo-r cassette.
(D) Brinp3 Southern Blot: splenic genomic DNA was cleaved with PstI and BglII and hybridized to 500 bp genomic DNA probes from the 5′ region (Ndel) and 3′ region
(PvuII) of the targeting construct. In wild-type DNA, species of 6.9 kb (Ndel) and 7.9 kb (PvuII) were detected. These products were not present in DNA from
Brinp3−/− mutants, replaced with shorter species of 4.5 kb (Ndel) and 7.2 kb (PvuII). (E) Validation of knock-out line using cDNA derived from brain tissue mRNA
from WT, heterozygous and Brinp2−/− Brinp3−/− Brinp2/3−/− Brinp1/2/3−/− mice. For each genotype, PCR product sizes correspond to the removal of exon3 in
the knock-out allele. (F) Sequencing of the Brinp2−/− and Brinp3−/− allele RT-PCR products showed the expected absence of exon 3, and that splicing fuses exons
2 and 4, resulting in a frame shift that introduces a stop codon after 50 (Brinp2−/−) and 18 (Brinp3−/−) residues. Sequencing results for Brinp1−/− allele can be
found in previously published work (Berkowicz et al., 2016).
Brinp2 (Brinp2tm1.1/Pib) were inter-bred to generate homozygous
Brinp2tm1.1Pib/tm1.1Pib (Brinp2−/−) animals and WT littermates.
Correct targeting and deletion of exon 3 was confirmed by
Southern analysis (Figure 1B), RT-PCR (Figure 1E), and DNA
sequencing of RT-PCR products (Figure 1F). The resultant
mRNA lacking exon 3 reflects forced splicing between the
intron 2 donor and intron 4 acceptor, fusing exons 2 and
4, and changing the reading frame to introduce a truncating
stop codon (Figure 1F). The predicted mutant protein would
comprise the cleavable signal peptide (33 aa) and 56 aa of the
750 aa mature BRINP2 protein, and contains no recognizable
functional domains. Hence this 56 aa form is missing over 92% of
the BRINP2 amino acid sequence, and would be highly unlikely
to fold correctly. It is therefore likely degraded shortly after
synthesis, which is the generally accepted fate of truncated or
misfolded proteins (Hiller et al., 1996).
Targeting of Brinp3 Knock-Out Mice
In an identical manner to the Brinp2 targeted mouse line, a
conditional Brinp3 targeted allele (Brinp3tm1/Pib) was designed
to allow Cre-recombinase-mediated, tissue-specific deletion of
Brinp3 (Figure 1C). Mice lacking Brinp3 in all tissues were
created by breeding animals carrying the Brinp3 targeted
allele with animals expressing global Cre-deleter mice. Progeny
exhibiting deletion of the selection cassette and third exon of
Brinp3 (Brinp3tm1.1/Pib) were inter-bred to generate homozygous
Brinp3tm1.1Pib/tm1.1Pib (Brinp3−/−) animals and WT littermates.
Deletion of exon 3 was confirmed by Southern analysis
(Figure 1D), RT-PCR (Figure 1E), and DNA sequencing of RT-
PCR products (Figure 1F). The resultant mRNA lacking exon 3
reflects forced splicing between the intron 2 donor and intron 4
acceptor, fusing exons 2 and 4, and changing the reading frame
to introduce a truncating stop codon (Figure 1F). The predicted
mutant protein would comprise the cleavable signal peptide (33
aa) and 44 aa of the 733 aa mature BRINP3 protein, and contains
no recognizable functional domains. Hence this 44 aa form is
missing over 93% of the BRINP3 amino acid sequence, and would
be highly unlikely to fold correctly, and therefore again likely
degraded shortly after synthesis.
Generation and Validation of Multigenic
Brinp Deletion
Validation of Brinp2/3−/− and Brinp1/2/3−/− mice was
performed by RT-PCR of cDNA derived from knock-out
mouse brain tissue of each genotype. Only PCR products of
sizes corresponding with the exon 3-deleted Brinp2tm1.1Pib
and Brinp3tm1.1Pib alleles were present for Brinp2/3−/− mice,
confirming homozygosity of both knock-out alleles (Figure 1E).
For the Brinp1/2/3−/− mouse cDNA, only PCR products
of sizes corresponding with the exon3-deleted Brinp1tm1.1Pib,
Brinp2tm1.1Pib, and Brinp3tm1.1Pib alleles were present, confirming
homozygosity of all three knock-out exon-3 deleted alleles
(Figure 1E).
Brinp2−/− and Brinp3−/− Mice Are Viable
and Appear at Mendelian Frequencies;
Brinp1/2/3−/− Mice Exhibit Poor Viability
Litters bred from Brinp2+/− or Brinp3+/− heterozygous crosses
were monitored for survival. Mice were genotyped at age of
weaning (day 21). Genotypes were assessed for Mendelian
inheritance (25% of total progeny expected to be knock-
out mice) as an indicator of normal in utero and neonatal
viability. Brinp2−/− and Brinp3−/− mice demonstrated close to
Mendelian inheritance for the number of knock-outs surviving
to age of weaning (Brinp2−/−: 9/50 = 22.5%, Brinp3−/−:
10/41 = 24%) and litter sizes from homozygous breeders were
normal (Brinp2−/−: 6.4 ± 2.9 SD), Brinp3−/−: 6.9 ± 1.9 SD).
Brinp2/3−/− homozygotes also produced litters of standard size
(6.0± 1.9 SD) indicating normal viability.
It proved difficult to generate practical numbers of viable
Brinp1/2/3−/− progeny due to both the low expected frequency
from triple heterozygous matings (1 in 16) and the compromised
postnatal viability of pups from mothers carrying the Brinp1−/−
alleles (see Berkowicz et al., 2016). Three triple-het breeders
mated for a total of 5 months produced three triple KO mice
at a frequency of 3/51 (5.9%), and therefore viable at close
to expected frequency of 1/16 (6.3%), however reduced overall
litter survival from triple het breeders meant only 3 out of
a total of 84 mice pups born were viable triple knock-out
mice (Table 1). To increase the likelihood of generating enough
triple knock-out mice for a minimum behavioral cohort of 10
within a similar age, female triple heterozygous breeders were
paired with male Brinp1+/−/2−/−/3−/− mice. These breeders
produced normal litter sizes at birth, but many progeny died
before weaning, similar to mice carrying Brinp1 knock-out
allele. The addition of the male mice carrying the Brinp2/3−/−
mutation resulted in a significant decrease in offspring survival
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TABLE 1 | Reproductive phenotyping: generation of Brinp1/2/3−/− triple
knock-out mice.
Female/Male
WT/WT Triple Het/ Triple Het/
Triple Het Brinp1−/+2−/−3−/−
Days from mating to first litter 25 23 28
Days between litters 37 33 30
Number of litters 14 10 14
Number of pups born (P0) 97 84 84
Number of pups weaned (P21)*** 76 51 25
% Survival 78 61 30
Number of viable Brinp1/2/3−/−
progeny
n/a 3 2
Three breeders per genotype (WT/WT, Triple-Het/ Triple-Het, Triple-Het
♀/Brinp1−/+2−/−3−/− ♂ were monitored over 5 months to investigate reproductive
rates, postnatal survival and viability of Brinp1/2/3−/− mice. Whilst there were no
significant differences in the numbers of pups born at postnatal day 0 (P0): X2(2, n=265) =
1.276 p = 0.30, Chi-square test, the survival of mice to age of weaning, postnatal day
(P21) was significantly impacted by the presence of Brinp1, Brinp2, and Brinp3 deleted
alleles carried by breeders: ***X2(2, n=152) = 25.67, p < 0.001; Chi-square test.
and indicates the absence of Brinp2 and Brinp3, when combined
with Brinp1 heterozygosity in the male breeder impacts litter
survival (Supplementary Figure 1). These limitationsmeant that
it was not possible to generate a triple knock-out behavioral
cohort within an appropriate age range.
Brinp2−/−, Brinp3−/−, Brinp2/3−/−, and
Brinp1/2/3−/− Mice Exhibit Reduced Body
Mass, but Normal Gross Morphology
Brinp2−/−, Brinp3−/−, Brinp2/3−/−, and Brinp1/2/3−/− mice
were weighed weekly from 3 to 12 weeks of age, alongside
their respective WT littermates. Knock-out mice from all four
lines showed some reduction in body mass. Female Brinp2−/−
mice displayed normal weight from infant to adult, whereas
male Brinp2−/− mice showed reduced body mass from 7 weeks
onwards, weighing 10% less as adults at week 12 (Figure 2A).
Brinp3−/− mice weighed less than their WT littermates in the
first few weeks of weighing (3–5 weeks) for both males and
females, before their weights recovered to that of their WT
littermates (Figure 2B). Female Brinp2/3−/− mice were smaller
in the first few weeks, before recovering to a weight similar to that
of WT. Male Brinp2/3−/− mice weighed less than WT controls
as adults (Figure 2C). Overall, Brinp2/3−/− mice show a trend in
bodymass reduction that reflects a combination of the Brinp2−/−
and Brinp3−/− mice weight profiles.
Female and male Brinp1/2/3−/− mice weighed significantly
less than WT littermates, and less than Brinp2−/−, Brinp3−/−,
or Brinp2/3−/− mice (Figure 2D). Triple Brinp knock-out mice
also weighed less the Brinp1−/− mice (Berkowicz et al., 2016),
indicating a cumulative effect of the triple gene knock-out on
body mass.
A full histological examination of juvenilemice for Brinp2−/−,
Brinp3−/−, Brinp2/3−/−, and Brinp1/2/3−/− mice at 7–8 weeks
of age showed normal organ development (25 organs examined)
including normal structures in the brain and spinal cord. In all
cases, brains appeared symmetrical, with normal myelination,
and no ventricular dilation observed (data not shown).
Brinp2−/−, Brinp3−/−, and Brinp2/3−/−
Mouse Behavior
To evaluate the effect of Brinp2 and Brinp3 loss on neurological
function, the behavior of the single and double knock-out lines
were assessed. In an initial screen, Brinp2−/− and Brinp3−/−
and Brinp2/3−/− mice showed normal auditory, visual, and
olfactory capabilities (Supplementary Figures 2A,B). Mice
showed no impairments in motor co-ordination on the Rotarod
(Supplementary Figures 3A–C), with female Brinp2−/− mice
showing improved performance on this test.
Brinp3−/− Knock-Out Mice Exhibit Marked
Changes in Exploratory Behavior
To examine whether anxiety was affected in the knock-out
mice, animals were allowed to freely explore an elevated plus
maze (EPM) for 5 min. Mice normally show a species-typical
preference for the walled closed arms, and show some hesitance
to enter the more exposed open arms. Mice that show a high level
of reluctance to approach the open arm are interpreted as having
an anxiety-like phenotype.
A pronounced phenotype was exhibited by male and female
Brinp3−/− mice, which spent significantly longer on the open
arms and center square, and less time in the closed arms
(Figure 3A), indicating reduced anxiety levels. The velocity of
Brinp3−/− mice was normal for this test, ruling out hyperactivity
(Figure 3B). Brinp3−/− mice showed a reduced latency time
to enter the open arm of the EPM (Figure 3C), and increased
number of entries into the open arms (Figure 3D). Additionally,
Brinp3−/− mice showed prolonged exploration time at the
exposed ends of the open arms (Figure 3E), and exhibited
peering down behavior at the edges of the open arms (Figure 3F).
In contrast to the Brinp3−/− mice, Brinp2−/− mice did not
show an increased preference for the open arms of the EPM,
indicating a normal response to potential danger (Figure 3G).
However, male but not female mice did show increased velocity
in the test, consistent with hyperactivity (Figure 3H).
An increase in open arm exploration was also apparent in the
Brinp2/3−/− mice (Figures 3I,J), consistent with the absence of
Brinp3 alone, suggesting that this reduced anxiety phenotype is
not modified by the absence of Brinp2.
Brinp2−/−, Brinp3−/−, and Brinp2/3−/−
Mice Exhibit Normal Sensory Gating and
Short-Term Memory
The startle response and PPI test is used to measure sensory
gating in mice, and models deficits in human subjects diagnosed
with schizophrenia. Brinp2−/−, Brinp3−/−, and Brinp2/3−/−
mice were able to inhibit the startle response when primed with
pre-pulses of 4, 8, and 16 dB (Supplementary Figures 4A,B). The
ability of all three knock-out lines to gate their startle response
indicates that these mice do not model this aspect of human
schizophrenia.
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FIGURE 2 | Brinp2, Brinp3, Brinp2/3, and Brinp1/2/3 weights. (A) Brinp2−/− mice weighed from week 3 to 12. Female Brinp2−/− mice show normal weight
between 3 and 12 weeks by repeat measures two-way ANOVA: F (1, 15) = 0.155, p = 0.699. Male Brinp2
−/− mice show a significant reduction in body weight from 6
weeks of age onwards. By repeat measures two-way ANOVA male Brinp2−/− mice show a significant interaction of genotype × week: F (9, 117) = 5.645, p < 0.001.
N = 8 females, 8 males per genotype. (B) Brinp3−/− mice weighed from week 3 to 12. Both Male and Female Brinp3−/− mice show reduced body mass from
(Continued)
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FIGURE 2 | Continued
weeks 3 to 5, before recovering to near normal weight from week 6 onwards. Female Brinp3−/− mice show a significant interaction of genotype × week:
F (8, 96) = 2.115, p = 0.042, repeat measures two-way ANOVA. Male Brinp3
−/− mice show a significant reduction in body weight to their littermates F (1, 12) = 8.602,
p = 0.013, and a significant genotype × week interaction F (9, 108) = 3.919, p < 0.001, repeat measures two-way ANOVA. N = 7 females, 7 males per genotype.
(C) Brinp2/3−/− mice weighed from week 3 to 12. Female Brinp2/3−/− mice show a significant week × genotype interaction effect: F (9, 117) = 3.065, p = 0.002.
Male Brinp2/3−/− mice show a significant decrease in body weight, analyzed by repeat measures two-way ANOVA: F (1, 14) = 6.228, p = 0.026, and a significant
interaction effect between week × genotype: F (9, 126) = 2.461, p = 0.013. N = 8 females, 8 males per genotype. (D) Brinp1/2/3
−/− mice weighed from week 3 to
12. Female Brinp1/2/3−/− mice show a significant reduction in body weight: F (1, 3) = 47.738, p = 0.007, with a significant interaction between week × genotype:
F (9, 27) = 5.736, p < 0.001, repeat measures two-way ANOVA, n = 3 WT, 2 Brinp1/2/3
−/− mice. Male Brinp1/2/3−/− mice also show a significant decrease in body
weight: F (1, 8) = 54.708, p < 0.001, with a significant interaction between week × genotype: F (8, 64) = 3.005, p = 0.006, repeat measures two-way ANOVA, n = 5
WT, 5 Brinp1/2/3−/− mice. Results represented as the mean ± SD.
Brinp2−/−, Brinp3−/−, and Brinp2/3−/− mice were tested for
spatial learning and memory in the Y-maze. Following a 2-h
interval after exploring the home and a single arm of the maze,
mice were recorded exploring the three arms of the maze. As
expected, WT control mice for each line preferred to explore
the novel arm in this test. All three knock-out lines tested also
showed the species-typical significant increase in time spent
exploring the novel arm compared to the familiar arm, indicating
normal short-term memory (Figures 4A–C). Brinp2−/− mice
moved at a statistically significantly increased velocity for this test
(Figure 4D), consistent with hyperactivity, whereas Brinp3−/−
and Brinp2/3−/− mice did not show a significant increase in
locomotor activity (Figures 4E,F).
Brinp3−/− and Brinp2/3−/− Mice Exhibit a
Mild Reduction in Sociability; Brinp2−/−
Mice Show Increased Locomotor Activity
The three chamber social interaction test is routinely used to
investigate sociability in rodents (Silverman et al., 2010). In the
habituation trial (trial 1) mice were allowed to explore the whole
arena, including left and right chambers containing empty cages.
Brinp2−/−, Brinp3−/−, and Brinp2/3−/− mice spent a normal
amount of time exploring the cages, without preference for left
or right chambers (Supplementary Figure 5A). Brinp2−/− mice
exhibited increased velocity in this trial (Figure 5A), resulting
an increased total distance traveled (Supplementary Figure 5B).
Neither Brinp3−/− nor Brinp2/3−/− mice showed significant
increases in velocity/distance traveled (Figure 5A and
Supplementary Figure 5B).
Whilst hyperactive, Brinp2−/− mice exhibited normal
sociability in this test. In contrast, Brinp3−/− females and
Brinp2/3−/− mice of both sexes did not show the expected
increase in interaction time when investigating the cage
containing a stranger mouse compared to an empty cage
(Figure 5B). No significant difference was detected between WT
and knock-outs (Brinp3−/− and Brinp2/3−/−) in the interaction
time with the stranger mouse. Overall, these finding suggest that
absence of Brinp3 reduces sociability.
DISCUSSION
In this study we have found that absence of Brinp2 or
Brinp3 alone or in combination has no overt effect on mouse
anatomy, reproduction, or viability, but has an age-specific
negative effect on bodyweight. Knockout mice exhibit behavioral
traits consistent with NDDs, including hyper-exploration,
hyperactivity and reduced sociability.
Brinp3−/− Mice Exhibit Hyper-Exploratory
Behavior
The reduced aversion of Brinp3−/− mice to the open arms of
the Elevated Plus Maze demonstrates these mice have an altered
response to potential danger: specifically, that the Brinp3−/−
anxiety response is lessened. A similar but less pronounced
phenotype is exhibited by Brinp1−/− mice (Kobayashi et al.,
2014; Berkowicz et al., 2016). The fact that both Brinp1−/− and
Brinp3−/− mice exhibit this phenotype, along with sociability
changes, may indicate a role for both genes in regulating anxiety
as well as sociability. Consistent with this suggestion, both Brinp1
and Brinp3 are highly expressed in the adult amygdala complex,
a brain region governing fear and other emotions (Prather et al.,
2001; Kalin et al., 2004).
The repetitive peering down behavior of Brinp3−/− mice
has been previously reported in the dopamine transporter
(DAT knock-out) mouse model for ADHD as the “cliff
avoidance reaction” (Yamashita et al., 2013), which could indicate
that changes in synaptic dopamine levels may contribute to
this behavior in Brinp3−/− mice. Another explanation could
be changes in levels of the stress-response neurotransmitter
norepinephrine in the Brinp3−/− mice, as Brinp3 expression
correlates with changes in norepinephrine levels (Goddard et al.,
2010; Karoly et al., 2012). Future steps to investigate underlying
physiology, as well as the use of fear response paradigms,
such as fear avoidance and fear conditioning, may further
elucidate the role of Brinp3 in relation to human anxiety
disorders.
Increased Locomotor Activity of Brinp2−/−
Mice
Brinp2−/− mice exhibit increased locomotor activity, a
phenotype also observed in Brinp1−/− mice (Kobayashi et al.,
2014; Berkowicz et al., 2016). This hyperactivity may model
the reported ADHD in patients with alterations at the 1q25.2
locus (Lesch et al., 2008; Romanos et al., 2008; Lionel et al.,
2014). To determine whether these mice show face validity for
human ADHD, the Brinp2−/− mice would require testing for
attention and impulsivity as key diagnostic criteria. The 5-choice
serial reaction time test is an ideal approach, as this paradigm
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FIGURE 3 | Brinp3−/− and Brinp2/3−/− mice show increased exploration of the Elevated Plus Maze. (A) Brinp3−/− mice spend more time in the open
arms relative to the closed arms of the maze, indicating reduced anxiety. Analysis by repeat measure ANOVA shows a genotype × arm interaction: Female:
F(2, 16) = 15.359, p < 0.001, male: F(2, 24) = 4.407, p = 0.023. N = 5 female, 7 male mice per genotype. (B) Normal Brinp3
−/− mice average velocity during EPM
testing, female: t(8) = 1.629,p = 0.142, male: t(12) = 0.731,p = 0.479, Student’s t-test. (C) Brinp3
−/− mice show a significantly reduced latency to enter the open
arm: t(22) = 2.187,p = 0.040, unpaired student t-test. (D) Brinp3
−/− show a significantly reduced number of entries into the closed arm: t(21) = 2.575,p = 0.018
and a significant increase into the open arm: t(21) = 5.334,p < 0.0001, unpaired Student’s t-test. (E) Brinp3
−/− mice spend significantly more time peering over the
edge of the open arms compared to WT littermates, t(14) = 7.190,p < 0.0001, Student’s t-test. (F) Brinp3
−/− mice spend significantly more time at the end of the
open arms (defined as >50% of arm length from center), t(14) = 4.346,p = 0.0007, unpaired Student’s t-test. (G) No significant effect on arm duration for Brinp2
−/−
mice, female: F(2, 20) = 0.552,p = 0.584, male: F(2, 20) = 0.483,p = 0.624, repeat measures two-way ANOVA. N = 6 female, 6 male mice per genotype. (H) Male
Brinp2−/− mice show increased average velocity during EPM testing, female: t(10) = 0.571,p = 0.581, male: t(9) = 2.95,p = 0.016, Student’s t-test. (I) Brinp2/3
−/−
mice: Analysis by repeat measure ANOVA shows a genotype × arm interaction for Brinp2/3−/− male mice for percentage time in each arm: Female:
F(2, 16) = 1.762,p = 0.203, male: F(2, 20) = 4.571,p = 0.023. N = 5 female, 6 male mice per genotype. (J) Normal Brinp2/3
−/− mice average velocity during EPM
testing, female: t(10) = 0.523,p = 0.616, male: t(10) = 0.055,p = 0.958, Student’s t-test. ns = not significant. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Female and male data was combined for graphs (C–F). Results represented as the mean ± SD.
has been established for assessing both attention and impulse
control in rodents (Higgins and Breysse, 2008; Asinof and Paine,
2014).
Brinp2−/− mice show a reduction in body weight as adults
(males only). This reduced body mass may reflect increased
energy expenditure due to hyperactivity. The enhanced Rotarod
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FIGURE 4 | Y-maze: normal short-term memory. (A) Brinp2−/− Y-maze: analysis by repeat measures two-way ANOVA shows no interaction effect between
genotype × arm; female: F (2, 20) = 0.842, p = 0.446, male: F (2, 20) = 1.521, p = 0.243. N = 6 female, 6 male mice per genotype. (B) Brinp3
−/− Y-maze: No
interaction effect between genotype × arm; female: F (2, 16) = 0.582, p = 0.574, male: F (2, 24) = 0.136, p = 0.874. N = 5 female, 7 male mice per genotype,
two-way repeat measures ANOVA. (C) Brinp2/3−/− Y-maze: No interaction effect between genotype × arm; female: F (2, 20) = 0.791, p = 0.467, male: F (2, 20) =
0.864, p = 0.436. N = 6 female, 6 male mice per genotype, two-way repeat measures ANOVA. (D) Brinp2−/− mice show increased average velocity during Y-maze
testing, female: t(10) = 2.637, p = 0.025, male: t(10) = 2.504, p = 0.037, Student’s t-test. (E) Normal Brinp3
−/− mice average velocity during Y-maze testing, female:
t(8) = 0.435, p = 0.675, male: t(12) = 1.694, p = 0.116, Student’s t-test. (F) Normal Brinp2/3
−/− mice average velocity during Y-maze testing, female: t(10) = 0.385
p = 0.709 male: t(10) = 0.082, p = 0.937, Student’s t-test.*p < 0.05, Data presented as the mean ± SD.
performance by female Brinp2−/− mice may also be due to
increased locomotor activity, as reported for other hyperactive
mice (Graham and Sidhu, 2010; Bohuslavova et al., 2016).
It is intriguing that Brinp2−/− mice are hyperactive, whilst
Brinp2/3−/− mice are not. Perhaps the absence of Brinp3 results
in behavior that reduces overall locomotor activity. For example,
frequent peering-down along the edges of the open arms of the
EPM would reduce overall horizontal plane velocity.
Brinp2/3−/− Mice Resemble Brinp3−/−
Mice
The phenotype of Brinp2/3−/− mice shows a high degree of
similarity to that of the Brinp3−/−mice. The weight profile is
almost identical, as is the hyper-exploratory phenotype detected
on the elevated plus maze, normal velocity in various tests,
and the changes in sociability. These results suggest that
apart perhaps from locomotor activity, there is no significant
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FIGURE 5 | Social interaction of Brinp2−/−, Brinp3−/−, and Brinp2/3−/− knock-out mice. (A) Velocity Trial 1: (i) Brinp2−/− mice exhibited increased average
velocity over 10 min trial interval whilst habituating to the area in trial 1, indicating hyperactivity. Female: p = 0.0035, Male: p = 0.0091, Student’s t-test. (ii) and (iii)
Brinp3−/− and Brinp2/3−/− showed normal activity (velocity) during the habituation trial. Brinp3−/− female: p = 0.5708 Brinp3−/− male: p = 0.6920, Brinp2/3−/−
female: p = 0.0938 Brinp2/3−/− male: p = 0.5956, Student’s t-test. (B) Social Interaction Trial 2: (i) Brinp2−/− mice display the expected significant increase in
interaction time with the stranger mouse compared to an empty cage, indicating normal sociability: Female: F (3, 23) = 17.598, p < 0.001, male: F (3, 22) = 8.310,
p < 0.001, one way ANOVA. Tukey HSD post-hoc test: Female: WT empty—WT stranger: p < 0.001, Brinp2−/− empty—Brinp2−/− stranger: p = 0.001, WT
empty—Brinp2−/− empty: p = 0.772, WT stranger—Brinp2−/− stranger: p = 0.297. Male: WT empty—WT stranger: p = 0.033, Brinp2−/− empty—Brinp2−/−
stranger: p = 0.001, WT empty—Brinp2−/− empty: p = 1.000, WT stranger—Brinp2−/− stranger: p = 0.582, N = 6 females, 6 males per genotype. (ii) Brinp3−/−
(female only) mice do not show a significant increase in interaction time with the stranger mouse compared to an empty cage: Brinp3−/− female: F (3, 19) = 7.057,
p = 0.003, male: F (3, 27) = 10.868, P < 0.001, one way ANOVA. Tukey HSD post-hoc test: Female: WT empty—WT stranger: p = 0.005, Brinp3
−/−
empty—Brinp3−/− stranger: p = 0.233, WT empty—Brinp3−/− empty: p = 0.993, WT stranger—Brinp3−/− stranger: p = 0.329. Male: WT empty—WT stranger: p
= 0.003, Brinp3−/− empty—Brinp3−/− stranger: p=0.003, WT empty—Brinp3−/− empty: p =0.977, WT stranger—Brinp3−/− stranger: p = 0.969, N = 5 females,
7 males per genotype. (iii) Brinp2/3−/− mice do not show a significant increase in interaction time with the stranger mouse compared to an empty cage: Brinp2/3−/−
female: F (3, 21) = 3.977, p = 0.025, male: F (3, 23) = 6.606, p = 0.003, one way ANOVA. Tukey HSD post-hoc test: Female: WT empty—WT stranger: p = 0.036,
(Continued)
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FIGURE 5 | Continued
Brinp2/3−/− empty—Brinp2/3−/− stranger: p = 0.399, WT empty—Brinp2/3−/− empty: p = 0.999, WT stranger—Brinp2/3−/− stranger: p = 0.722. Male: WT
empty—WT stranger: p = 0.006, Brinp2/3−/− empty—Brinp2/3−/− stranger: p = 0.229, WT empty—Brinp2/3−/− empty: p = 1.000, WT stranger—Brinp2/3−/−
stranger: p = 0.321, N = 6 females, 6 males per genotype. ns = not significant. *p < 0.05, **p < 0.01, ***p < 0.001. Data presented as the mean ± SD.
phenotypic alteration or enhancement in the double knock-out
mice compared to the single knock-out mice. Therefore, the
genes do not compensate to mask phenotypic behaviors of the
single knock-out mice.
Brinp2 and Brinp3 show partial overlap in expression profile
during development, including co-expression in brain regions
that include the cerebellum, neocortex, and olfactory bulb
(Kawano et al., 2004). It is however notable that there are regions
where Brinp2 and Brinp3 show distinct expression profiles, e.g.,
Brinp2 is highly expressed in the CA1, CA2, and CA3 regions of
the adult hippocampus, whilst Brinp3 is predominantly expressed
in the dentate gyrus. Brinp3 also shows broader expression in
the cerebellum (Kawano et al., 2004). Taken with our findings,
this suggests that either Brinp2/Brinp3 have distinct molecular
functions, or Brinp2 and Brinp3 carry out the same role, but
function in distinct neuronal subtypes.
Comparison with the Brinp1−/− Mice
Phenotype
Comparing Brinp2−/− and Brinp3−/− mice phenotypes to
previously reported Brinp1−/− mice (Kobayashi et al., 2014;
Berkowicz et al., 2016), it is evident that there is some areas
of overlap, but overall mice do not show the same breadth of
severity as the Brinp1−/− mice. For instance, neither Brinp2−/−
or Brinp3−/−mice exhibit reduced viability, impaired short-term
memory and do not show the same degree of reduced sociability
or decreased body weight. This is consistent with the observation
that Brinp1 is the most highly and ubiquitously expressed of the
three genes during brain development (Kawano et al., 2004). The
overlap in some, but not all phenotypes between mice lacking
Brinp2−/− or Brinp3−/− with the Brinp1−/− mice indicates
possible shared Brinp1–Brinp2 and Brinp1–Brinp3 molecular
functions.
Brinp1/2/3−/− Mice: Initial Insights into
Mice Lacking All Brinps
The poor survival of litters from Brinp1/2/3 heterozygous
breeders is likely related to the absence of Brinp1, as we
have previously reported (Berkowicz et al., 2016). Although the
additional absence of Brinp2 and Brinp3 likely exacerbates the
phenotype, as appears to be the case when viability of litters drops
further when male mice of genotype Brinp1−/+2−/−3−/− are
bred with female triple-het mice. This drop in viability of litters
above that of litters heterozygous for all three Brinp genes may be
due to the cumulative effect of the absence of Brinp3 and Brinp1
in reducing sociability, and therefore affecting parental care of
offspring. Altogether, a different breeding strategy, or a much
larger breeding colony of triple-hets is needed for generating
sufficient numbers of triple KO out mice for a behavioral testing
cohort of 10 mice of a similar age.
The survival past weaning of some Brinp1/2/3−/− triple
knock-out mice indicates that Brinps are not essential for
embryonic or neonatal development. The absence of all three
Brinps results in an ostensibly normal, but significantly smaller
mouse, with normal gross morphology of all neural and
non-neural tissue, implying that Brinps are not essential for
organogenesis or neurogenesis. The normal gross anatomy of the
Brinp1/2/3−/− mice is surprising given the high expression of
Brinps in overlapping regions duringmurine neural development
(Kawano et al., 2004). A greater level of histopathological
analysis, using layer specific markers, is needed to determine
whether Brinp1/2/3−/− mice have altered neural architecture.
The reduction in body weight of Brinp1/2/3−/− mice may
reflect the observed phenotype of Brinp1−/− mice. Male
Brinp1/2/3−/−mice especially are significantly smaller from even
the Brinp1−/− mice (Berkowicz et al., 2016). This may be the
additive effect of the reduced body weight of Brinp1−/− and
Brinp2−/− mice, both of which weigh less than WT as adults.
CONCLUDING REMARKS
This study is a first step in understanding the effect of Brinp2
and Brinp3 genes on cognitive function. The observed changes in
Brinp3−/− anxiety response, and increased Brinp2−/− locomotor
activity may be relevant to the genetic variation at the 1q25.2
locus associated with patients diagnosed with ADHD, anxiety
and other NDDs. Brinp2−/− and Brinp3−/− genes do not appear
to compensate in the mammalian brain and are therefore likely
have distinct molecular or cell specific functions.
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Supplementary Figure 1 | Reduced litter survival when breeding Triple-het
and Triple-het × Brinp1−/+2−/−3−/− mice. Breeders were monitored for litter
size at birth and litter size at age of weaning (P21). (A) No significant differences in
number of pups per litter at postnatal day 0, from WT/WT, Triple-Het/Triple-Het
and Triple-Het ♀/Brinp1−/+2−/−3−/− ♂ parents, F (2, 35) = 2.702, p = 0.0811,
one-way ANOVA. (B) The combined Brinp1, Brinp2, and Brinp3 deleted allele of
breeders impacted the number of pups weaned at postnatal day 21, from WT/WT,
Triple-Het/ Triple-Het and Triple-Het ♀/Brinp1−/+2−/−3−/− ♂ parents.
F (2, 35) = 7.142, p<0.0025, one-way ANOVA. Tukey HSD multiple comparisons
tests showed significant differences: WT × WT and Triple-Het × Triple-Het:
p = 0.842, WT × WT and Triple-Het × Brinp1−/+2−/−3−/−: p = 0.0025,
Triple-Het × Triple-Het and Triple-Het × Brinp1−/+2−/−3−/−:
p = 0.027.∗p < 0.05, ∗∗p < 0.001, N = 3 breeding pairs per genotype, 10–14
litters per genotype.
Supplementary Figure 2 | Vision and Olfaction. (A) Normal vision for
Brinp2−/−, Brinp3−/− and Brinp2/3−/− mice: (i) Brinp2−/− Vision test female:
t(10) = 0.674, p = 0.516 male: t(10) = 0.277, p = 0.787, Student’s t-test. (ii)
Brinp3 Vision test female: t(8) = 1.265, p = 0.242 male: t(12) = 0.000, p > 0.999,
Student’s t-test. (iii) Brinp2/3 Vision test female: t(9) = 0.302, p = 0.770 male:
t(10) = 0.568, p = 0.583, Student’s t-test. (B) Normal olfaction for Brinp2
−/− and
Brinp3−/− mice: (i) Brinp2 Olfaction female: F (1,10) = 1.773, p = 0.213, male:
F (1, 10) = 0.081, p = 0.781, repeat measures two-way ANOVA. (ii) Brinp3
Olfaction female: F (1, 8) = 1.513, p = 0.254, male: F (1, 12) = 0.538, p = 0.477,
repeat measures two-way ANOVA. Data presented as the mean ± SD.
Supplementary Figure 3 | Rotarod. (A) Female Brinp2−/− mice show
significant improvement in latency to fall on the Rotarod; female:
F (1, 10) = 10.464, p = 0.009, male: F (1, 10) = 0.769, p = 0.401, repeat
measures two-way ANOVA. N = 6 female, 6 male mice per genotype.
(B) Brinp3−/− mice do not show significant motor co-ordination impairment
on the Rotarod; female: F (1, 8) = 1.337, p = 0.281, male F (1, 12) = 1.483,
p = 0.247, repeat measures two-way ANOVA. N = 5 female, 7 male mice per
genotype. (C) Brinp2/3−/− mice do not show significant motor co-ordination
impairment on the Rotarod; female: F (1, 8) = 1.560, p = 0.247, male
F (1, 10) = 0.087, p = 0.774, repeat measures two-way ANOVA. N = 6
female, 6 male mice per genotype. Data presented as the mean ± SD.
Supplementary Figure 4 | Startle and Pre-pulse Inhibition (PPI). (A) Normal
startle response for Brinp2, Brinp3, and Brinp2/3 mice: (i) Brinp2−/− startle
female: t(9) = 0.1178, p = 0.908, male: t(10) = 0.4818, p = 0.640, Student’s
t-test. (ii) Brinp3−/− startle female: t(8) = 0.6158, p = 0.555, male:
t(12) = 0.2630, p = 0.797, Student’s t-test. (iii) Brinp2/3
−/− startle female:
t(9) = 0.7216, p = 0.489, male: t(10) = 0.2195, p = 0.831, Student’s t-test.
(B) Normal Pre Pulse Inhibition (PPI) for Brinp2−/−, Brinp3−/−, and
Brinp2/3−/− mice: (i) Brinp2−/− PPI female: F (1, 10) = 3.551, p = 0.089,
male: F (1, 10) = 0.783, p = 0.397, repeat measures two-way ANOVA. (ii)
Brinp3−/− PPI female: F (1, 8) = 0.276, p = 0.614, male: F (1, 12) = 0.056,
p = 0.817, repeat measures two-way ANOVA. (iii) Brinp2/3−/− PPI female:
F (1, 9) = 0.056, p = 0.818, male: F (1, 10) = 0.133, p = 0.753, repeat
measures two-way ANOVA. Data presented as the mean ± SD.
Supplementary Figure 5 | Habituation trial of three-chamber social
interaction test (Trial 1). (A) Habituation trial of the three chamber social
interaction test, showing interaction time between empty cages. No significant
preference between the left/right chambers for Brinp2−/−, Brinp3−/−, or
Brinp2/3−/− mice. (i) Brinp2−/− SI Test Trial 1: female: F (3, 23 = 0.371,
p = 0.775, male: F (3, 23) = 0.119, p = 0.948, one-way ANOVA, N = 6 females, 6
males per genotype. (ii) Brinp3−/− SI Test Trial 1: female: F (3, 19) = 0.399,
p = 0.756, male: F (3, 27) = 1.144, p = 0.352, one-way ANOVA, N = 5 females, 7
males per genotype. (iii) Brinp2/3−/− SI Test Trial 1: female: F (3, 23) = 0.621,
p = 0.609, male: F (3, 21) = 0.086, p = 0.967, one-way ANOVA, N = 6 females, 6
males per genotype. (B) Distance Travelled Trial 1. (i) Brinp2−/− mice traveled a
significantly increased distance over 10min trial interval whilst habituating to the
arena, indicating hyperactivity. Female: p = 0.0163, male: p = 0.0061, Student’s
t-test. (ii–iii) Brinp3−/− and Brinp2/3−/− showed normal activity (distance
traveled) during the habituation trial. Brinp3−/− female: p = 0.5199, Brinp3−/−
male: p = 0.6300, Brinp2/3−/− female: p = 0.5030, Brinp2/3−/− male: p =
0.4608, Student’s t-test.
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